相关实验视频

Updated: May 6, 2026

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

缺乏CXCL16可缓解小鼠卵胺诱导的过敏性鼻炎

Meihua Kong¹, Qian He²

¹Department of ENT, Yueqing People's Hospital, Wenzhou, Zhejiang Province, China; m_hkong0322@163.com.

Allergologia et immunopathologia

|July 19, 2025

概括

缺乏CXCL16可缓解小鼠过敏性鼻炎. 淘汰CXCL16可以减少过敏症状,炎症标志物和组织损伤,这表明它在过敏性鼻炎中起着至关重要的作用.

科学领域:

免疫学免疫学免疫学
呼吸系统医学呼吸系统医学

背景情况:

在过敏性鼻炎患者中观察到高CXCL16血清水平.
CXCL16与炎症反应有关.

研究的目的:

在过敏性鼻炎的小鼠模型中研究CXCL16的作用.
阐明CXCL16在这种情况下的功能背后的机制.

主要方法:

卵胺 (OVA) 诱导的过敏性鼻炎模型在小鼠中.
对CXCL16mRNA和蛋白质表达的测量.
评估过敏症状,IgE/IgG1水平,炎症因素和蛋白质信号通路 (NF-κB).

主要成果:

OVA挑战增加了CXCL16的表达.
CXCL16淘汰赛减少了过敏症状 (打喷,鼻),并抑制了IgE/IgG1水平.
缺乏CXCL16减少了支气管洗液中的炎症细胞和因素,缓解了组织病理,并调节了NF-κB信号传递.

结论:

CXCL16在过敏性鼻炎的发病过程中起着重要作用.
缺乏CXCL16证明了通过减轻过敏性鼻炎症状和炎症的治疗潜力.

关键词:

在CXCL16中,CXCL16是CXCL16的代号.在 NF-κBB 中.过敏性鼻炎过敏性鼻炎这是一种炎症炎症炎症炎症.

更多相关视频

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System

Published on: September 20, 2019

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

相关概念视频

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...